CFDE Data Portal | Search LGI1

	Label	Description
	LGI1 Gene (Entity type)	ENSG00000108231 - leucine rich glioma inactivated 1
	LGI1 associations Collection (Entity type)	Associations for LGI1_associations
	LGI1 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	LGI1 HUMAN Protein (Entity type)	Leucine-rich glioma-inactivated protein 1 (precursor)
	LGI1 MOUSE Protein (Entity type)	Leucine-rich glioma-inactivated protein 1 (precursor)
	LGI1 RAT Protein (Entity type)	Leucine-rich glioma-inactivated protein 1 (precursor)
	LGI1 BOVIN Protein (Entity type)	Leucine-rich glioma-inactivated protein 1 (precursor)
	GSE101239 5 V 6 VALPROIC ACID MOUSE UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE109285 3 V 2 GLUCAGON MOUSE UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE234647 1 V 3 REGORAFENIB HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS

LGI1

ENSG00000108231 - leucine rich glioma inactivated 1

LGI1 associations

Associations for LGI1_associations

LGI1 associations.tsv

A file from IDG as part of the Harmonizome project

LGI1 HUMAN

Leucine-rich glioma-inactivated protein 1 (precursor)

LGI1 MOUSE

Leucine-rich glioma-inactivated protein 1 (precursor)

LGI1 RAT

Leucine-rich glioma-inactivated protein 1 (precursor)

LGI1 BOVIN

Leucine-rich glioma-inactivated protein 1 (precursor)

GSE101239 5 V 6 VALPROIC ACID MOUSE UP

A Gene Set from LINCS

GSE109285 3 V 2 GLUCAGON MOUSE UP

A Gene Set from LINCS

GSE234647 1 V 3 REGORAFENIB HUMAN UP

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.